TrialSiteNews

Join The Conversation! | https://trialsitenews.com/ Do doctors have the right to quote research results, even if they are disputed, challenged, or represent some controversial stance opposed to a formal government position? What if the data is the result from their own research or real-world care? The answer around the world, is ever increasingly no, as national governments pressure medical professional licensing bodies and health systems, indirectly, to punish any medical providers that promulgate “misinformation.”

In this must watch episode of Whistleblower with Shabnam Palesa Mohamed, frontliners Dr Stefaan Oosthuizen and Dr EV Rapiti share their experiences of extensive patient vaccine injuries, difficulties in reporting to the South African government, the regulator SAHPRA, and the injections manufacturer, and treatment protocols they use to help people. Aware of the severe underreporting of vaccine injuries, they support criminal charges and civil claims against individuals and companies pushing the C19 injections on people, without informed consent. Both brave doctors hope that more whistleblowers will speak out. Website: www.TrialSiteNews.com Telegram: t.me/TrialSiteNews

Join The Conversation! | https://trialsitenews.com/ Published recently in the prestigious New England Journal of Medicine (NEJM), a study led by Massachusetts-based physician-scientists leads to a disturbing discovery: individuals fully vaccinated and boosted against COVID-19 actually recover markedly more slowly from the illness and surprisingly, even remain contagious for lengthier periods of time as compared to unvaccinated persons. While the study didn’t investigate implications associated with illness severity, the findings nonetheless raise significant questions for consideration. This study was approved by the institutional review board and the institutional biosafety committee at Mass General Brigham, and informed consent was obtained from all the participants. The takeaway from this study could be profound should the results scale out to larger cohorts. People that are vaccinated remain five times as contagious as those who are unvaccinated ten days after SARS-CoV-2 infection. Put another way, the vaccinated continue to transmit the disease significantly more than the unvaccinated should the data hold up across broader investigation.

Summit Therapeutics announced topline results from the Phase III Ri-CoDIFy study evaluating ridinilazole for the treatment of and Sustained Clinical Response (SCR) for patients suffering from C. difficile infection (C. diff. infection or CDI). The study showed that ridinilazole resulted in a higher observed SCR rate than vancomycin but did not meet the study’s primary endpoint for superiority. SCR is defined as Clinical Response of the treated episode of CDI and no recurrence of the infection through 30 days after the end of treatment. Patients treated with ridinilazole experienced substantially less recurrence of C. diff. infection as compared to patients administered vancomycin. In this study recurrence was defined as a new episode of diarrhea (?3 unformed bowel movements) in a 1-day period with a positive C. difficile test that requires CDI antimicrobial treatment in subjects who achieved Clinical Response.

Join The Conversation! | https://trialsitenews.com/ Dr. Klausner is a world renowned infectious disease and public health expert currently with Keck School of Medicine at the University of Southern California. He is also a professor of population and public health sciences and his research interests include applied epidemiology and the prevention and control of infectious diseases of public health importance, including HIV, STDs, TB and COVID-19.

Is 'safe and effective' fraudulent misrepresentation? Is censorship of science misrepresentation? Is non-disclosure of conflicts of interest fraud through omission? What about uninformed consent? In this first episode of Law vs Science, Shabnam Palesa Mohamed engages multi-skilled scientist Dr Jessica Rose, veteran OBGYN expert Dr James Thorpe, and clinical researcher and Pfizer whistle-blower Brook Jackson on the strongest evidence of fraud in the C19 jab trial. Each with uncensored perspectives, these experts believe that fraud, misrepresentation, negligence, and omission continues to happen, and must result in accountability. But from whom? Who is 'the government'? And what is the dire premonition about growing public anger? Website: www.trialsitenews.com Telegram: t.me/TrialSiteNews #LawVsScience #TrialsiteNews #Uncensored #HealthScience

Dr. Thorp Says Women Should Think Twice Before Getting a COVID-19 Vaccine Amid Concerning Data on Pregnancy, Fertility, and the Menstrual Cycle Dr. Jim Thorp is a board-certified in obstetrician-gynecologist and maternal fetal medicine physician with more than 42 years of obstetrical experience. While serving as a clinician, he has also been active in clinical research with over 175 publications. Dr. Thorp currently sees 6,000 to 7,000 high-risk pregnancies per year. He has served as a reviewer for major medical journals and served on the Board of Directors for the Society of Maternal Fetal Medicine for four years. Most recently, Dr. Thorp has focused his research efforts on the COVID-19 pandemic and published several peer-reviewed scientific publications documenting the dangers of the vaccine in women of reproductive age and in pregnancy. Online link to World Health Council slides referenced in the video to include in BIO: https://1drv.ms/p/s!AlDFWnm0kirJqX5pvS8M_sP9D3wF

Iveric Bio has a drug in its pipeline that has the company excited for the future: Zimura. Zimura is an investigational complement C5 inhibitor that is designed to decrease the activation of inflammasomes and the formation of membrane attack complex (MAC). The company believes Zimura could treat Geographic Atrophy (GA) secondary to dry age-related macular degeneration (AMD) by preventing or slowing the degeneration of retinal pigment epithelial cells.

Dr. Jim Thorp is a board-certified in obstetrician-gynecologist and maternal fetal medicine physician with more than 42 years of obstetrical experience. While serving as a clinician, he has also been active in clinical research with over 175 publications. Dr. Thorp currently sees 6,000 to 7,000 high-risk pregnancies per year. He has served as a reviewer for major medical journals and served on the Board of Directors for the Society of Maternal Fetal Medicine for four years. Most recently, Dr. Thorp has focused his research efforts on the COVID-19 pandemic and published several peer-reviewed scientific publications documenting the dangers of the vaccine in women of reproductive age and in pregnancy. He invites anyone who has been injured by a COVID-19 and is willing to share their story to contact him at jathorp@bellsouth.net. Links: PHMPT 5.3.6 Cumulative Analysis of Post-authorization Adverse Event Reports: Pfizer https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf My Cycle Story Patient BetrayalThe Corruption of Healthcare,Informed Consent and thePhysician-Patient Relationship https://covid19criticalcare.com/wp-content/uploads/2022/06/Dr-James-Thorp-Jun-15.pdf

Join The Conversation! | https://trialsitenews.com/ Article | A legal clash pitting healthcare employees that opted out of the COVID-19 vaccine mandates for religious motivations against a sizable Midwestern integrated health system has been settled by the parties based on a $10.3 million negotiated agreement that now just simply needs execution by a federal judge. Billed by the plaintiff’s counsel as the first-class action lawsuit settlement against a private employer concerning the COVID-19 vaccine mandates, the conflict started when fourteen healthcare employees, including nurses, a pharmacy tech, and a senior application analyst filed a lawsuit last October against the defendant, NorthShore University HealthSystem. The employees were named anonymously in the litigation.

In this first episode of Whistleblower, Shabnam Palesa Mohamed speaks with a veteran registered nurse who has chosen to speak out because she believe medical practices "are killing people" and "we need to save lives". To protect patients, 'Susan' shares harrowing experiences of C19 patient trauma and post jab injuries including heart attacks, brain damage and death. According to Susan, 300 C19 patients who died could have been saved had the hospital changed their protocols and avoided drugs like Midozolam. Adding to the impact, is the targeting and victimisation of staff who dare to speak out for their patients.

Join The Conversation! | https://trialsitenews.com/ A conversation with TrialSite News Founder and Patrick Girondi, who discusses his legal battle to get blood disorder drug released.

Join The Conversation! | https://trialsitenews.com/ Just a week ago, TrialSite News reported that COVID-19 cases in Japan were surging again, part of a seventh wave of COVID-19 infection due to the highly contagious BA.5 Omicron sub-variant now circulating around this island nation of nearly 126 million people. This media reported that 81% of the population is fully vaccinated, with about 58% of the population boosted.

Join The Conversation! | https://trialsitenews.com/ In this episode, Ali Holland, Executive General Manager of Digital and Decentralized Solutions at Medable and Joel Morse, CEO of Curavit Clinical Research, discuss the current state of decentralized clinical trials.

Join The Conversation! | https://trialsitenews.com/ In what is deemed the largest study thus far investigating the impact of COVID-19 vaccination on menstrual cycles, a controversial area that organized medicine initially shunned, investigators determined that 42% of women participating in this study reported heavier bleeding during their menstrual cycles post vaccine administration. Observational Study Link | https://www.science.org/doi/10.1126/sciadv.abm7201 NIH Study Link | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976114/

Natural and complementary medicine is a highly contested space globally. Even the WHO wants to be involved and set up a Traditional, Complementary and Integrative Medicine department. In South Africa, the Supreme Court of Appeal (SCA) upheld the judgement of the Gauteng North High Court, which struck down the controversial 2017 Complementary Medicine regulations under the Medicines Act. Both the High Court and SCA unanimously agreed that the South African Health Products Authority (SAHPRA) has no legal jurisdiction to regulate substances that are not medicines or scheduled substances. The verdict follows after the Alliance of Natural Health Products South Africa (ANHP), took the Minister of Health and the SAHPRA to court over contested regulations that would regulate all natural health products, defined as complementary medicines and health supplements, as medicines. Watch TSN's Shabnam Palesa Mohamed unpack the case and the implications with lawyer Danmari Deguid and indigenous medicine advocate Menzi Maseko

Vertex Pharmaceuticals, a biotech based in Boston, is acquiring ViaCyte’s stem-cell derived cell replacement therapies to take the next step of providing a cure for Type 1 diabetes (T1D) to the public. In fact, they’re buying the whole company for 320 million dollars. Back in February, ViaCyte and partner CRISPR Therapeutics dosed their first patient in a Phase I trial of VCTX210 for T1D. The therapy is an investigational, patient-derived, gene-edited, immune-evasive, stem cell therapy. The therapy combines CRISPR’s gene-editing expertise with ViaCyte’s proprietary pluripotent stem cell line. VCTX210 produces pancreatic cells that won’t be rejected by the patient’s immune system but should differentiate into pancreatic endoderm cells, which will then produce insulin.

South Africa's labour law landscape is robust, and in general, protects workers rights when unfairly treated. The exception to this principle became evident during C19, where countless workers were dismissed for refusing to be vaccinated, citing necessity, safety and efficacy. It appears that the dismissal tide is now turning against SA's high unemployment rate. In this interview by Shabnam Palesa Mohamed, we find out how the employee in this case won a decisive victory based on the expertise of medical expert Dr EV Rapiti and legal argument by attorney Quentin Horn. Proving insight on the applicant's experience is private investigator, Melissa Moller. How did the employee win 12 months in compensation?

Join The Conversation! | https://trialsitenews.com/ Two prominent figures in the past Trump administration have come forward to declare the actions by federal agencies such as the U.S. Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), and others overstepped their boundaries, turning into what they claim is an illegal crusade against the generic drug ivermectin. The well-known neurosurgeon Dr. Ben Carson, a founder of the American Cornerstone Institute, served the previous POTUS as U.S. Secretary of Housing and Urban Development, while attorney C. Boyden Gray served as White House Counsel, U.S. Ambassador to the European Union and a special envoy on behalf of the U.S. to Europe for Eurasia.

AstraZeneca is boosting its roster with the acquisition of TeneoTwo, which currently has a Phase 1 trial testing its newest treatment for blood cancer, in a deal valued up to 1.27 billion dollars. The transaction, expected to close in the third quarter of this year, includes TNB-486, which is part of a class of therapeutic antibodies called T-cell engagers. These are emerging as promising treatments for solid tumors and hematologic malignancies. The drug is also being considered for diffuse large B-cell lymphoma and follicular lymphoma. Bringing TeneoTwo into the fold allows Astrazeneca to build on the success of Calquence and further strengthen its pipeline.

Alexandra Latypova ("Sasha") is a retired pharmaceutical industry executive and entrepreneur. She holds an MBA degree from Dartmouth College and spent approximately 25 years in pharmaceutical research and development. Sasha later co-founded several clinical research organizations working as a contractor for about 60 pharmaceutical companies worldwide and was involved in the design, execution, data collection, analysis and submission of data to the FDA on hundreds of clinical trials. She also interacted with the FDA as part of the scientific consortium that developed new guidance for cardiovascular safety assessments of drugs and worked in all therapeutic areas and in many countries. Sasha currently holds board positions with several medical device and health care companies.

Join The Conversation! | https://trialsitenews.com/ Patrick Finley Girondi, originally from the South Side of Chicago, is an Italian-American singer-songwriter, author, and founder of San Rocco Therapeutics. Girondi is a respected and well-known leader in the field of rare diseases and has traveled all over the world counseling medical centers on their strategies to be more effective in the rare disease camp. Girondi is trusted and esteemed by many patient organizations including and not limited to, Cooley’s Anemia International, Think India, Thalassemics India, Giambrone Foundation and the Piera Cutina Foundation.

Dave Hickey, Executive Vice President and President of Life Sciences, BD, demonstrates AI-Powered, Home Test for COVID-19

Flávio Cadegiani is a medical doctor and board-certified endocrinologist with a master's and Ph.D. in clinical endocrinology. He is the founder of the Corpmetria Institute in Brazil and has more than 35 publications in PubMed. He is well known for his research on androgens and COVID-19 and endocrine-related therapies.

Join The Conversation! | https://trialsitenews.com/ The first wave of what TrialSite refers to as Version 1.0 COVID-19 vaccines were part of a public health communications scheme that was as much political and economic in nature as it was health and science-related. From the start, a confluence of national public health and research agencies, regulators, and industry discussed eradicating the SARS-CoV-2 pathogen, despite the fact that it was a volatile, dynamic, and mutation-prone RNA virus.